65--COVID-19 Rapid at home test kit for fire program

expired opportunity(Expired)
From: Federal Government(Federal)
140L3721Q0010

Basic Details

started - 11 Mar, 2021 (about 3 years ago)

Start Date

11 Mar, 2021 (about 3 years ago)
due - 01 Apr, 2021 (about 3 years ago)

Due Date

01 Apr, 2021 (about 3 years ago)
Bid Notification

Type

Bid Notification
140L3721Q0010

Identifier

140L3721Q0010
INTERIOR, DEPARTMENT OF THE

Customer / Agency

INTERIOR, DEPARTMENT OF THE (64336)BUREAU OF LAND MANAGEMENT (10477)NATIONAL INTERAGENCY FIRE CENTER (404)
unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

The Bureau of Land Management (BLM) at the National Interagency Fire Center (NIFC) intends to negotiate with only one source, Lucira Health Inc., 1412 62nd Street, Emeryville, California for 9072 each COVID-19 All in One Test Kits. This action is authorized by and in accordance with FAR 6.302-1. The Government believes that the only responsible source capable of satisfying the agency's requirement is Lucira Health Inc.. The Lucira COVID-19 All-in-One Test Kit is the only FDA authorized molecular diagnostic test for self-testing that provides rapid results (in 30 minutes or less). A Justification for Other than Full and Open Competition has been prepared in support of this acquisition and a copy of the Justification can be requested. The estimated value of this acquisition is less than $454,000.00. No Request for Quotation (RFQ) will be issued, and no response will be made to letters, emails or telephone requests for a copy of the solicitation. This is not a request for competitive quotes but serves as a procurement notice to fulfill public posting requirements in accordance with FAR 5.101(a)(1). The requirement is unrestricted and the NAICS code 339112 applies. Responsible firms believing they can provide the required items are encouraged to identify themselves and give written notification to the Contracting Officer referencing action item 140L3721Q0010, however, they must provide convincing evidence that they can furnish the requested items at a cost that will not exceed the total estimated transaction cost. All responses will be fully considered. If no affirmative responses are received by March 25, 2021 to the effect that a comparable source exists, an order will be placed with Lucira Health Inc. for the requirement stated here. Questions concerning this acquisition may be directed to Diane Barker at 208-387-5544 or emailed to

3833 SOUTH DEVELOPMENT AVENUE  BOISE , ID 83705  USALocation

Place Of Performance : 3833 SOUTH DEVELOPMENT AVENUE BOISE , ID 83705 USA

Country : United StatesState : Idaho

You may also like

OVER THE COUNTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

EO14042 - VACCINE MANDATE FOR COVID19 INFO - KAPPA LAMBA AND HEVY LITE TESTING KITS

Due: 14 Jun, 2025 (in 13 months)Agency: VETERANS AFFAIRS, DEPARTMENT OF

OVER THE CONTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

naicsCode 339112Surgical and Medical Instrument Manufacturing
pscCode 6505Drugs and Biologicals